This record was last updated September 5, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.